These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2151149)
1. [Plasma atrial natriuretic peptide level and urinary fractional sodium excretion (FENa) in patients with chronic renal failure]. Czekalski S Pol Arch Med Wewn; 1990 Dec; 84(6):370-7. PubMed ID: 2151149 [TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide and adaptation of sodium urinary excretion in patients with chronic renal failure. Czekalski S; Michel C; Dussaule JC; Touraine P; Mignon F; Ardaillou R Clin Sci (Lond); 1988 Sep; 75(3):243-9. PubMed ID: 2970911 [TBL] [Abstract][Full Text] [Related]
3. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor. Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure. Dussaule JC; Michel C; Peraldi MN; Lecomte JM; Gros C; Mignon F; Ardaillou R Clin Sci (Lond); 1993 Jan; 84(1):31-9. PubMed ID: 8382131 [TBL] [Abstract][Full Text] [Related]
8. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography. Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271 [TBL] [Abstract][Full Text] [Related]
9. Effects of sodium intake, furosemide, and infusion of atrial natriuretic peptide on the urinary and metabolic clearances of arginine vasopressin in normal subjects. Moses AM; Jones C; Yucha CB J Clin Endocrinol Metab; 1990 Jan; 70(1):222-9. PubMed ID: 2136743 [TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome. Plum J; Mirzaian Y; Grabensee B Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965 [TBL] [Abstract][Full Text] [Related]
11. Is urodilatin the missing link in exercise-dependent renal sodium retention? Schmidt W; Bub A; Meyer M; Weiss T; Schneider G; Maassen N; Forssmann WG J Appl Physiol (1985); 1998 Jan; 84(1):123-8. PubMed ID: 9451626 [TBL] [Abstract][Full Text] [Related]
12. Association between atrial natriuretic peptide and cyclic GMP in hypertension and in chronic renal failure. Sagnella GA; Saggar-Malik AK; Buckley MG; Markandu ND; Eastwood JB; MacGregor GA Clin Chim Acta; 1998 Jul; 275(1):9-18. PubMed ID: 9706839 [TBL] [Abstract][Full Text] [Related]
13. Plasma concentration and renal effect of human atrial natriuretic peptide in nephrotic syndrome. Hisanaga S; Yamamoto Y; Kida O; Kato J; Fujimoto S; Tanaka K Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):661-9. PubMed ID: 2529385 [TBL] [Abstract][Full Text] [Related]
14. Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome. Burnier M; Mooser V; Wauters JP; Marder HK; De Vane P; Nussberger J; Waeber B; Brunner HR J Cardiovasc Pharmacol; 1989 May; 13(5):682-90. PubMed ID: 2472515 [TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide in kidney of renal disease patients and healthy persons. Marumo F; Sakamoto H; Umetani N; Okubo M Endocrinol Jpn; 1988 Aug; 35(4):523-9. PubMed ID: 2975217 [TBL] [Abstract][Full Text] [Related]